A prospective and retrospective multicenter cohort study of hepatocellular carcionoma development in patients after hepatitis C virus eradication

A prospective and retrospective multicenter cohort study of hepatocellular carcionoma development in patients after hepatitis C virus eradication - SMART-C V4

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000023997

Enrollment

2000

Registered

2016-09-10

Start date

2015-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients after eradication of hepatitis C virus

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Informed consent was obtained from each patient. (If written consent could not be obtained because patients were already dead or changed hospitals, information disclosure of this study on institution's website could be equated to obtained consent. 2) Chronic hepatitis C patients with or without cirrhosis who had achieved sustained virological response by antiviral therapies.

Exclusion criteria

Exclusion criteria: 1) Patients who developed hepatocellular carcinoma before achieved sustained virological response. 2) Patients with hepatitis B virus or human immunodeficiency virus co-infection. 3) Patients who physicians considered unsuitable for this study.

Design outcomes

Primary

Measure	Time frame
Incidence of hepatocellular carcinoma after hepatitis C virus eradication	—

Secondary

Measure	Time frame
Overall survival rate	—

Countries

Japan

Contacts

Public ContactTateishi Ryosuke

Graduate School of Medicine, the University ofTokyo Department of Gastroenterology

tateishi-tky@umin.ac.jp+81-3-3815-5411

Outcome results